Barriers to scaling up hepatitis C treatment in Malaysia: a qualitative study with key stakeholders

BACKGROUND: While the availability of generic direct-acting antivirals (DAAs) opens the door for large-scale treatment, the care for people living with hepatitis C virus (HCV) in Malaysia is shifting toward a tripartite partnership between the public health system, correctional settings and civil so...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Huan-Keat, Hassali, Mohamed Azmi, Mohammed, Noor Syahireen, Azlan, Azlina, Hassan, Muhammad Radzi Abu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860373/
https://www.ncbi.nlm.nih.gov/pubmed/35189876
http://dx.doi.org/10.1186/s12889-022-12786-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860373/
https://www.ncbi.nlm.nih.gov/pubmed/35189876
http://dx.doi.org/10.1186/s12889-022-12786-w

Ejemplares similares